inVentiv Health Opens State-of-the-Art Office in Maidenhead, United Kingdom, to Respond to Accelerated Demand for Services in Europe

LONDON – inVentiv Health, offering best-in-class clinical, commercial and consulting services, has consolidated three Greater London offices into a single, state-of-the-art office space in Maidenhead, Berkshire. The new office will allow the company to better service its European customer base.

The newly-constructed, built-to-suit space allows for improved integration and knowledge-sharing across inVenitv's clinical, commercial and consulting businesses. The three-storey building initially will house 180 employees with space to accommodate many more over the coming months.

Theresa May, Member of Parliament for Maidenhead and Home Secretary, attended a ribbon- cutting ceremony commemorating the opening of the new office. inVentiv executives joining her at the event included Susan C. Stansfield, Executive Vice President, Global Clinical Operations and Project Management Office; Stephen Preece, Senior Vice President, Human Resources; and Steve Mitchell, Senior Director, Clinical Data Management.

Following the ribbon cutting, the Home Secretary spoke to a large group of inVentiv employees.

Paul Meister, Chairman and Chief Executive Officer of inVentiv Health, said the new office was "an important milestone in the expansion of our company as it allows us to successfully meet the needs of our clinical, commercial and consulting workforce. inVentiv's global footprint continues to expand and the Maidenhead office will play a central role."

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to the life sciences industry. inVentiv offers convergent services that accelerate the performance of companies working to improve human life. In 40 countries around the world, inVentiv's 12,000 employees work with more than 550 pharmaceutical, biotech and device companies, as well as companies that see health as a central part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. inVentiv Health helps clients transform promising ideas into commercial reality. For more information, visit

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.